Professor Richard Fielding, BA (Hons), Dip Clin Psych, PhD (Hong Kong)
Richard Fielding graduated in Psychology & Zoology from the University of London in 1974, completed his clinical psychology training in Manchester establishing one of the first cardiac rehabilitation programmes and support groups for women with breast cancer in the UK. After finishing a PhD from the University of Sheffield in medical psychology, he moved east, joining HKU as Assistant Professor in Medical Psychology in 1982. His research interests include social aspects of cancer and optimization of care for patients with chronic illness. He retired from full-time academia in 2017 but remains Honourary Professor of Medical Psychology in Public Health. He was formerly Head of the Behavioural Sciences Unit, and Director of CePORT, the Centre for Psycho-Oncology Research & Training, and of the Health Behaviour Research Group in the School of Public Health at HKU. Professor Fielding is on the Editorial Boards of the journals Psycho-Oncology, Health Psychology and Public Health, amongst others and has authored over 220 peer-reviewed papers, books and chapters. He is a recipient of the BMA Medical Book of the Year Award for his text on Clinical Communication Skills and has served in various board and committee positions of the International Psycho-Oncology Society, and is a founder member of the Asia-Pacific Psycho-Oncology Network. He is currently co-Chair of the Scientific Committee of the 2018 World Congress of Psycho-Oncology.
Professor Brian Kelly, BMed (Newcastle), PhD, FRANZCP, FAChPM (Australia)
Professor Brian Kelly is Dean of Medicine – Joint Medical Program, Head of the School of Medicine and Public Health and Professor of Psychiatry at the University of Newcastle, Australia. He has a longstanding background in clinical research addressing the psychosocial aspects of cancer and palliative care. Prof Kelly has undertaken large scale longitudinal cohort and intervention studies across mental health, palliative and end-of-life care, and psycho-oncology including research to explore ways to improve identification of psychosocial needs, health service models in psycho-oncology and integration of psychosocial care into cancer services. He has a broad interest in the strategies to improve education and support of health professionals in oncology and palliative care, including methods of clinical supervision and support, education in communication skills, and addressing the impact of care on clinicians. He has conducted research focussed on the patterns of psychiatric symptoms and disorder experienced by people with cancer, the doctor-patient relationship in end-of-life care in cancer, and longitudinal studies of bereavement in the cancer context, focussing on family and caregiver outcomes. His experience also extends to research and clinical service development addressing health care needs and services in rural and remote regions, and the psychosocial needs of Indigenous people with cancer. He extensive experience as a clinician in the field of Consultation-Liaison Psychiatry with a focus on oncology and palliative care. Prof Kelly has contributed to national and international leadership roles including the Australian Psycho-oncology Co-operative Research Group and Chair of the IPOS Governance Committee. As Adjunct Professor in the Department of Oncology, with the Cummings School of Medicine, University of Calgary and Tom Baker Cancer Centre, he has also played a leadership role in the promotion of a unique cross-national collaboration in Psycho-oncology research.
Dr. Lili Tang, MD (China)
Dr. Lili Tang is the Director of the Department of Psycho-Oncology in Peking University Cancer Hospital. She is also the first psychiatrist involving in palliative care and psycho-oncology in Mainland China. In 2005, Dr. Tang went to Memorial Sloan Kettering Cancer Center and Tom Baker Cancer center as a visiting scholar. In these two famous Cancer Center, Dr. Tang gained lots of experience and guidance. She provides symptom management and psychotherapy for both outpatients and inpatients. During over last two decades, she and her team have served more than 20000 cancer patients. She edited the first textbook of Psycho-oncology in 2012 and set up curriculum on psycho-oncology for postgraduate students majoring in Clinical oncology in Peking University in 2015. She has been the president of Chinese Psycho-Oncology Society (CPOS) and Beijing Psycho-Oncology Society (BPOS) since 2013. With her effort, CPOS has been developing rapidly and become an academic organization with more than 2000 members. Under her leadership, CPOS helped twenty caner hospitals set up psychosocial services, distributed in 18/34 provinces in China. In 2016, under her advocacy and organization, CPOS published the first Chinese Psychosocial Oncology Therapy Guidelines for Cancer patient in China, which represented a milestone in the development of Chinese psycho-oncology clinical practice. Supported by the funding from Chinese government, Dr. Lili Tang has built international collaboration in Asian, America, Canada and Australia to hold trainings on psycho-oncology, palliative care and doctor-patient communication all over the country and to conduct researches in these fields and her department has been evaluated as the model Unit of Chinese standardized training of psychosocial service and doctor-patient communication in cancer patients (2015.12-2020.12).
Dr. Fiona Schulte, PhD (Canada)
Fiona Schulte is an Assistant Professor in the Department of Oncology, Division of Psychosocial Oncology in the Cumming School of Medicine at the University of Calgary. She is also a registered psychologist in the Hematology, Oncology and Transplant Program at the Alberta Children’s Hospital. Fiona is Vice-President of the Canadian Association of Psychosocial Oncology and a member of a number of national and international committees focused on improving the care of pediatric and adolescent cancer patients, survivors and their families. Fiona’s research is broadly interested in enhancing the patient and family experience for patients diagnosed with cancer and improving the psychosocial late effects of childhood cancer survivors. She has been recognized for her research by receiving an International Society of Pediatric Oncology Young Investigator Award and Calgary’s Avenue Magazine Top 40 Under 40.
